Reactive astrocytes are astrocytes undergoing morphological, molecular, and functional
remodeling in response to injury, disease, or infection of the CNS. Although this remodeling …

Neurodegenerative disorders such as Alzheimer's disease (AD) represent a mounting public
health challenge. As these diseases are difficult to diagnose clinically, biomarkers of …

Using induced pluripotent stem cells (iPSCs) to understand the mechanisms of neurological
disease holds great promise; however, there is a lack of well-curated lines from a large array …

Background and purpose Neurological manifestations in coronavirus disease (COVID)‐
2019 may adversely affect clinical outcomes. Severe COVID‐19 and uremia are risk factors …

Mild traumatic brain injury (mTBI) accounts for approximately 80% of all TBI cases and is a
growing source of morbidity and mortality worldwide. To improve the management of …

Mucosal-associated invariant T (MAIT) cells are unconventional T cells that recognize
microbial riboflavin pathway metabolites presented by evolutionarily conserved MR1 …

SARS-CoV-2 infection shows a wide-ranging clinical severity, requiring prognostic markers.
We focused on S100B, a calcium-binding protein present in biological fluids, being a …

Pesticides are omnipresent, and they pose significant environmental and health risks.
Translational studies indicate that acute exposure to high pesticide levels is detrimental, and …

Prevalence of mental disorders, including major depressive disorder (MDD), bipolar
disorder (BD) and schizophrenia (SZ) are increasing at alarming rates in our societies …

Neurological disorders (ND) are the central nervous system (CNS) related complications
originated by enhanced oxidative stress, mitochondrial failure and overexpression of …